Message #19 From:
Stock News Bot Date: September 1, 2006 06:24:00 AM
CLSN News The Chelsea Collection Inc. Welcomes Baby Boomers; Chelsea Collection Inc. G-H-3-Plus Proven Anti-Aging Protocol Big Boost to Boomers
LAS VEGAS--(BUSINESS WIRE)--Sept. 1, 2006--The Chelsea Collection (Pink Sheets:CLSN), announced that the Company now has a proven medical protocol available to address the issues of aging and vitality for the 78 million plus baby boomers in the United States. Boomers' spent over $50 billion dollars last year on anti-aging services, cosmetic oriented products, and supplements to keep them looking and feeling young, vibrant and healthy.
The authorized clinic to offer the G-H-3 Plus(R) protocol is Kozmary Center for Pain Management in Las Vegas. "The company is very excited that we can now offer the G-H-3 Plus(R) protocol in America," said Flo Ternes, president and CEO. "This will allow baby boomers and others who are concerned about the effects of aging and disease to utilize this proven and effective treatment without the expense and hassle of traveling to another country." Up until now, the G-H-3 Plus(R) protocol, developed by world renowned geriatric doctor and researcher Dr. Ana Aslan, has only been available in European clinics. The Company is in the process of finalizing its marketing plan and anticipates bringing the therapy to the general public in September.
This document contains 'forward looking statements' concerning CLSN operations and strategies, including its future economic performance, intent, plans, objectives and the likelihood of success in developing and expanding the business. These statements are based upon assumptions and estimates that are subject to significant uncertainties, many of which are beyond CLSN's control. Words such as "may," "would," "could," "will," "expect," "anticipate," "intend," "plan," and "estimate," are meant to identify such forward looking statements. Actual results may differ materially from those expressed or implied by such forward-looking statements. The company assumes no obligation to update this information.
